GlassScriptPhysician profile
Gladys G De Leon
NPI 1841250867
$8,248.56
in general payments reported to CMS, 2019-2025
15 companies · $434 in 2025
The $434 reported for 2025 was more than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $1,309 · 2021: $2,834 · 2022: $2,950 · 2023: $502 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $894 · Travel and Lodging: $42.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $893.79 |
| Travel and Lodging | $42.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,643.36 | 2021-2022 | |
| Rock Medical Orthopedics, INC. | $3,151.91 | 2020-2022 | |
| Linvatec Corporation | $421.20 | 2023-2025 | Quantum, Colink 2, Neospan Superelastic Compression Staple W/Instruments, Size 10x10x10 |
| Convatec INC. | $218.48 | 2023 | |
| Sanara Medtech INC. | $174.57 | 2025 | Celleraterx |
| Stryker Corporation | $138.89 | 2022 | |
| Aroa Biosurgery Incorporated | $132.34 | 2019-2025 | |
| Integra Lifesciences Corporation | $102.00 | 2019 | |
| In2bones USA, LLC | $81.29 | 2019 | |
| Spr Therapeutics, INC | $76.52 | 2022 | |
| Smith+Nephew, INC. | $34.76 | 2021-2022 | |
| Baxter Healthcare | $26.40 | 2019 | |
| Kci USA, INC. | $21.39 | 2020 | |
| Polarityte, INC. | $13.41 | 2020 | |
| Horizon Therapeutics Plc | $12.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gladys De Leon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.